Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-024132
Filing Date
2025-02-20
Accepted
2025-02-20 16:05:08
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6360
  Complete submission text file 0000950170-25-024132.txt   7920
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GERON CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address
SCARLETT JOHN A (Reporting) CIK: 0001270928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 25645232